Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

SEARCH GUIDE  Download Search Tip PDF File

  • articleNo Access

    Preparation and characterization of novel magnetic nanocomposite-bonded metalloporphyrins as biomimetic nanocatalysts

    In this work, novel magnetic nanocomposite-bonded metalloporphyrins were synthesized by an effective silanation approach between 3-aminopropyltriethoxysilane derivatized metalloporphyrins and silica-coated magnetic Fe3O4 nanoparticles. The initial metalloporphyrin derivatives were synthesized by the amidation reaction of metalloporphyrin acyl chloride with 3-aminopropyltriethoxysilane. After the metalloporphyrin derivatives were adsorbed on the surface of silica-coated magnetic Fe3O4 nanoparticles, the solid mixture was heated under vacuum at 110 °C for 3 h and then thoroughly washed with chloroform. The obtained magnetic nanocomposite-bonded metalloporphyrins were characterized by elemental analyzer, low-temperature N2 adsorption (BET method), transmission electron microscopy, UV-vis spectroscopy, and infrared spectroscopy. Interestingly, using this particular silanation method, metalloporphyrins could be quantitative-immobilized in magnetic nanocomposites by controlling the input ratio of metalloporphyrins and silica-coated magnetic Fe3O4 nanoparticles. The excellent catalytic activity and recyclability of the magnetic nanocomposite-bonded metalloporphyrins were demonstrated in the cyclohexane oxidation with iodosylbenzene.

  • chapterNo Access

    BIOLOGICAL AND MECHANICAL PROPERTIES OF COMMERCIAL PMMA BONE CEMENTS CONTAINING AW-GC FILLER

    Bioceramics01 Oct 1999

    We reported previously that a bioactive PMMA-based cement was obtained by using a dry method of silanation of AW-GC particles, and using high molecular weight PMMA beads. In this report, commercial PMMA bone cements (CMW1, Surgical Simplex) containing AW-GC filler in the ratio of 70wt% were investigated (abbreviated as B-CMW1 and B-Surg Simp). Their handling properties were similar to the commercial CMW1 cement that does not contain bioactrve powder (C-CMW1) as dough and setting times were 3 and 8 minutes respectively for both types of bioactive cements compared to 2 and 6 minutes respectively for C-CMW1. Bending strength of plates made from both bioactive cements and C-CMW1 cement was 90 ± 7 MPa for B-CMW1 and 98 ± 7 MPa for B-Surg Simp compared to 92±6 MPa for C-CMW1 after one day of immersion in simulated body fluid (SBF). These cements were also implanted in the medullary canals of rat tibiae. After 4 and 8 weeks of implantation, the bone-cement interface was examined using scanning electron microscope and Giemsa surface staining and the affinity index was calculated. After 8 weeks it was 55.5±10.8 for B-CMW1 and 49.4 ± 4.6 for B-Surg Simp compared to 2.0±1.4 for C-CMW1 indicating higher bioacivity than that previously reported.